ROMAN SHULKIN: Open Payments
NPI 1710307731 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,928 in 83 payments from 14 companies in 2025. Trend: 2023 $1,926 · 2024 $2,720 · 2025 $2,928
Food & beverage: $2,928
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $816 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $317 |
| Boston Scientific Corporation | 3 | $277 |
| ABBVIE INC. | 11 | $270 |
| SI-BONE, INC. | 2 | $225 |
| SCILEX PHARMACEUTICALS INC. | 10 | $195 |
| Eisai Inc. | 7 | $188 |
| Saluda Medical Americas, Inc. | 1 | $164 |
| Valinor Pharma, LLC | 10 | $157 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $153 |
Products named: INTELLIS ADAPTIVESTIM, RELISTOR, INCEPTIV, ZTLido, Leqembi, General - Therapies, Evoke, MOVANTIK.
Industry payments across NY — which companies pay providers there.
